|Bid||74.03 x 900|
|Ask||74.04 x 800|
|Day's Range||73.16 - 75.04|
|52 Week Range||63.60 - 89.74|
|Beta (5Y Monthly)||0.39|
|PE Ratio (TTM)||17.03|
|Earnings Date||Oct 25, 2023 - Oct 30, 2023|
|Forward Dividend & Yield||3.00 (4.00%)|
|Ex-Dividend Date||Sept 14, 2023|
|1y Target Est||85.99|
In the latest trading session, Gilead Sciences (GILD) closed at $74.10, marking a -1.12% move from the previous day.
FOSTER CITY, Calif., October 02, 2023--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Kevin E. Lofton, Lead Independent Director, has been named one of the most influential leaders in corporate governance by the National Association of Corporate Directors (NACD) as part of their 2023 NACD Directorship 100™, an annual list of leading corporate directors and governance advocates.
There's no better time than October to invest in high-quality dividend stocks. Three Motley Fool contributors believe they've identified magnificent dividend stocks to buy in October. Here's why they chose AbbVie (NYSE: ABBV), Gilead Sciences (NASDAQ: GILD), and Johnson & Johnson (NYSE: JNJ).